180 related articles for article (PubMed ID: 33910857)
1. Effect of Prophylactic Anti-emetics on Opioid-induced Nausea and Vomiting: A Retrospective Observational Cohort Study.
Tamura T; Kawakado K; Makimoto GO; Nakanishi M; Kuyama S
In Vivo; 2021; 35(3):1737-1742. PubMed ID: 33910857
[TBL] [Abstract][Full Text] [Related]
2. Use of Prophylactic Ondansetron with Intravenous Opioids in Emergency Department Patients: A Prospective Observational Pilot Study.
Culver MA; Richards EC; Jarrell DH; Edwards CJ
J Emerg Med; 2017 Nov; 53(5):629-634. PubMed ID: 28987314
[TBL] [Abstract][Full Text] [Related]
3. Investigating the efficacy and safety of olanzapine prophylaxis for opioid-induced nausea and vomiting (JORTC-PAL20): a study protocol for an open-label, single-arm exploratory study.
Satomi E; Kobayashi T; Ishikawa A; Arakawa S; Ishiki H; Amano K; Sakiyama N; Ariyoshi K; Kihara K; Oyamada S; Mizushima A
BMJ Open; 2024 Feb; 14(2):e076575. PubMed ID: 38417963
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
Tsukuura H; Miyazaki M; Morita T; Sugishita M; Kato H; Murasaki Y; Gyawali B; Kubo Y; Ando M; Kondo M; Yamada K; Hasegawa Y; Ando Y
Oncologist; 2018 Mar; 23(3):367-374. PubMed ID: 29038236
[TBL] [Abstract][Full Text] [Related]
5. Economic and clinical burden of opioid-induced nausea and vomiting.
Nicholson BD
Postgrad Med; 2017 Jan; 129(1):111-117. PubMed ID: 27690715
[TBL] [Abstract][Full Text] [Related]
6. Opioid induced nausea and vomiting.
Smith HS; Laufer A
Eur J Pharmacol; 2014 Jan; 722():67-78. PubMed ID: 24157979
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.
Giusti R; Mazzotta M; Filetti M; Daniele G; Tsukuura H; Ficorella C; Porzio G; Marchetti P; Verna L
Support Care Cancer; 2019 Sep; 27(9):3531-3535. PubMed ID: 30684048
[TBL] [Abstract][Full Text] [Related]
8. Anti-emetic therapy in cancer chemotherapy: current status.
Herrstedt J; Dombernowsky P
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjects.
Ellero C; Han J; Bhavsar S; Cirincione BB; Deyoung MB; Gray AL; Yushmanova I; Anderson PW
Diabet Med; 2010 Oct; 27(10):1168-73. PubMed ID: 20854385
[TBL] [Abstract][Full Text] [Related]
11. 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
Olver I; Clark-Snow R; Ruhlmann CH; Garcia-Del-Barrio MA; Schwartzberg L; Rapoport BL; Jahn F
Support Care Cancer; 2023 Dec; 32(1):37. PubMed ID: 38110581
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Use of Antiemetics for Prevention of Opioid-Induced Nausea and Vomiting: A Questionnaire Survey among Japanese Physicians.
Tsukuura H; Ando Y; Gyawali B; Matsumoto M; Sugishita M; Honda K; Urakawa H; Maeda O; Hasegawa Y
J Palliat Med; 2015 Nov; 18(11):977-80. PubMed ID: 26509390
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary?
Kanbayashi Y; Hosokawa T
J Palliat Med; 2014 Jun; 17(6):683-7. PubMed ID: 24702605
[TBL] [Abstract][Full Text] [Related]
14. [Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study].
Nukariya N; Kobayashi K; Ishihara Y; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
Gan To Kagaku Ryoho; 1996 May; 23(6):757-71. PubMed ID: 8645027
[TBL] [Abstract][Full Text] [Related]
15. Intravenous dexamethasone for prophylaxis of postoperative nausea and vomiting after administration of long-acting neuraxial opioids: a systematic review and meta-analysis.
Grape S; Usmanova I; Kirkham KR; Albrecht E
Anaesthesia; 2018 Apr; 73(4):480-489. PubMed ID: 29226971
[TBL] [Abstract][Full Text] [Related]
16. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
[TBL] [Abstract][Full Text] [Related]
17. Ondansetron is more effective than metoclopramide for the treatment of opioid-induced emesis in post-surgical adult patients. Ondansetron OIE Post-Surgical Study Group.
Chung F; Lane R; Spraggs C; McQuade B; Jacka M; Luttropp HH; Alahuta S; Rocherieux S; Roy M; Duvaldestin P; Curtis P
Eur J Anaesthesiol; 1999 Oct; 16(10):669-77. PubMed ID: 10583349
[TBL] [Abstract][Full Text] [Related]
18. An audit of chemotherapy-induced nausea and vomiting in children.
Clinton F; Dowling M; Capra M
Nurs Child Young People; 2012 Sep; 24(7):18-23. PubMed ID: 23155937
[TBL] [Abstract][Full Text] [Related]
19. Compliance with National Comprehensive Cancer Network anti-emesis guidelines in a Community Hospital Cancer Center.
Daniel D; Waddell A
J Oncol Pharm Pract; 2016 Feb; 22(1):26-30. PubMed ID: 25122634
[TBL] [Abstract][Full Text] [Related]
20. A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting.
Sato J; Tanaka R; Ishikawa H; Suzuki T; Shino M
Support Care Cancer; 2020 Mar; 28(3):1083-1088. PubMed ID: 31183560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
